Literature DB >> 18271874

DNA repair dysfunction in gastrointestinal tract cancers.

Yoshihiko Maehara1, Akinori Egashira, Eiji Oki, Yoshihiro Kakeji, Teruhisa Tsuzuki.   

Abstract

The DNA repair system surveys the genome, which is always suffering from exposure to both exogenous as well as endogenous mutagens, to maintain the genetic information. The fact that the basis of this DNA repair system is highly conserved, from prokaryote to mammalian cells, suggests the importance of precise genome maintenance mechanisms for organisms. In the past 15 years, considerable progress has been made in understanding how repair processes interact and how disruptions of these mechanisms lead to the accumulation of mutations and carcinogenesis. In 1993, two groups reported that DNA mismatch repair could be associated with hereditary non-polyposis colorectal cancer, indicating a connection between faulty DNA repair function and cancer. More recently, an inherited disorder of DNA glycosylase, which removes mutagenic oxidized base from DNA, has been reported in individuals with a predisposition to multiple colorectal adenomas and carcinomas. This is the first report that directly indicates the role of the repair of oxidative DNA in human inherited cancer. Studies from gene knockout mice have elucidated the principal role of these repair systems in the process of carcinogenesis. Moreover, clinical samples derived from cancer patients have shown the direct involvement. This review focuses on the function of DNA mismatch repair and oxidative DNA/nucleotide repair among various DNA repair systems in cells, both of which are essentially involved in the carcinogenesis of gastrointestinal tract cancer.

Entities:  

Mesh:

Year:  2008        PMID: 18271874     DOI: 10.1111/j.1349-7006.2007.00671.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  3 in total

Review 1.  DNA damage and neurotoxicity of chronic alcohol abuse.

Authors:  Inna I Kruman; George I Henderson; Susan E Bergeson
Journal:  Exp Biol Med (Maywood)       Date:  2012-07-24

2.  ARID1A expression in gastric adenocarcinoma: clinicopathological significance and correlation with DNA mismatch repair status.

Authors:  Ryo Inada; Shigeki Sekine; Hirokazu Taniguchi; Hitoshi Tsuda; Hitoshi Katai; Toshiyoshi Fujiwara; Ryoji Kushima
Journal:  World J Gastroenterol       Date:  2015-02-21       Impact factor: 5.742

Review 3.  Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer.

Authors:  Nicola Carlomagno; Paola Incollingo; Vincenzo Tammaro; Gaia Peluso; Niccolò Rupealta; Gaetano Chiacchio; Maria Laura Sandoval Sotelo; Gianluca Minieri; Antonio Pisani; Eleonora Riccio; Massimo Sabbatini; Umberto Marcello Bracale; Armando Calogero; Concetta Anna Dodaro; Michele Santangelo
Journal:  Biomed Res Int       Date:  2017-09-28       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.